KMT2D and lymphoma: CREBBP, KMT2D, and EZH2 are thus frequent epigenetic hits, initially considered as direct tumor inducers regulating B-cell proliferation and differentiation, but now widely recognized for their additional role as modulators of lymphoma TME, in particular based on the data obtained in GEMM.